<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">To employ the Expanded Access mechanism, both acute antiviral treatments and prophylactic vaccines can be expected to be widely distributed under a treatment IND as soon as a manufactured product is available and evaluated by the FDA.</p>
